Liu, W., Wei, Y., Chen, J., Xing, X., Jia, H., Yang, X., . . . Ma, D. Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC/CDK2/DNMT1 pathway. Nature Portfolio.
Chicago Style (17th ed.) CitationLiu, Wan-cheng, et al. Inhibition of Tumor-intrinsic NAT10 Enhances Antitumor Immunity by Triggering Type I Interferon Response via MYC/CDK2/DNMT1 Pathway. Nature Portfolio.
MLA (9th ed.) CitationLiu, Wan-cheng, et al. Inhibition of Tumor-intrinsic NAT10 Enhances Antitumor Immunity by Triggering Type I Interferon Response via MYC/CDK2/DNMT1 Pathway. Nature Portfolio.
Warning: These citations may not always be 100% accurate.